백혈구 성분채집술 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00005515
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 190
Buy Now

[연구보고서] 백혈구 성분채집술 시장은 2021년 7,448만 달러에서 2028년 1억 3,390만 달러에 달할 것으로 예상된다. 2021년부터 2028년까지 CAGR 8.7%로 성장할 것으로 추정됩니다.



백혈구 성분채집술은 신체의 면역 반응에 관여하는 백혈구(백혈구)를 혈액 샘플에서 분리하는 절차입니다. 이것은 적혈구나 혈소판과 같은 혈액의 요소를 얻고 나머지 혈액은 순환 상태로 회복시키는 특별한 형태의 성분채집법입니다. 백혈구 성분채집술은 종종 만성 림프구성 백혈병(CLL)과 같은 만성 혈액암과 같은 매우 높은 백혈구(WBC) 수를 줄이는 데 사용됩니다. 또한 암 화학 요법을 통해 백혈구 수의 급격한 감소를 관리하는 것과 같이 나중에 이식할 백혈구를 얻기 위해 완료할 수 있습니다. 또 다른 용도는 백혈병, 전립선암 및 기타 형태의 암과 싸우는 데 도움이 되는 키메라 항원 수용체(CAR) T 세포 요법이라고 하는 새로운 형태의 면역 요법의 한 부분입니다. 백혈구 성분채집술은 치료를 원하는 사람(자가 성분채집술) 또는 이후 이식을 위한 기증자(동종 성분채집술)에서 완료할 수 있습니다. 현재 백혈구성분채집술은 각종 질병의 치료에 많이 사용되고 있으며, 순환하는 종양세포의 수율을 높일 수 있어 진단용으로도 사용되고 있다. 자발적인 헌혈자 수 증가, 혈액 질환 발병률 증가, 노인 인구 급증과 같은 요인이 백혈구 성분채집술 시장 성장을 촉진하고 있습니다. 그러나 백혈구 성분채집술의 높은 비용은 시장의 성장을 어느 정도 방해합니다.



백혈구 성분채집 시장의 유리한 지역

시장 통찰력



수혈은 여러 국가의 국가 보건 인프라 및 정책의 필수적인 부분입니다. 의료 산업의 발전으로 심각한 질병과 부상의 치료 절차가 개선되었고 결국 환자에게 수혈이 필요하게 되었습니다. 활착. 의료 서비스에서 수혈 및 혈액 가용성의 중요성에 대한 인식이 높아지면서 의료 목적을 위해 기꺼이 혈액을 기증하려는 사람들의 수가 증가했습니다. 세계보건기구(WHO) 데이터에 따르면 2018년 전 세계적으로 약 1억 1,740만 건의 헌혈이 보고되었습니다. 헌혈자는 일반적으로 자발적 무급, 유급, 가족/대체 헌혈자로 분류되며, WHO 주장에 따라 자발적/무급 헌혈자로 분류됩니다. 안정적이고 적절한 혈액 공급의 주요 공급원입니다. 2019년 WHO 데이터에 따르면 자발적인 무상 헌혈자의 헌혈은 2008년부터 2015년까지 전 세계 139개국에서 1,160만 건 증가했다. 헌혈 추세는 저소득 및 중간 소득 국가에서도 두드러지고 있습니다. 2017년 CAG 연례 회의에서 발표된 데이터에 따르면 2016년에 1,087명의 환자에게 약 13,000건의 시술이 시행되었습니다. 자발적 헌혈자 수가 가장 많이 급증한 국가는 동남아시아 국가(83%)와 아메리카(70%)였습니다. .



많은 국가에서 개발되고 시행되는 국가 프로그램은 많은 수의 혈소판 및 혈액 기증자를 유치하고 있습니다. 예를 들어, 인도에서는 NACO(National AIDS Control Organization) 내에 구성된 NBTC(National Blood Transfusion Council)가 SACS(State AIDS Control Societies) 내에 설립된 SBTC(State Blood Transfusion Council)와 조정하는 중앙 기관입니다. ). NBTC는 수혈 서비스(BTS)와 관련된 다양한 활동을 위한 건강 프로그램을 지원합니다. 따라서 전 세계 여러 국가에서 적격 기증자의 수가 증가함에 따라 필요한 혈액 성분을 분리하는 데 사용되는 백혈구 성분채집술 장비의 필요성이 높아지고 있습니다.



제품 유형 기반 통찰력



제품 유형에 따라 백혈구 성분채집 시장은 백혈구 성분채집 장치와 백혈구 성분채집 일회용품으로 나뉩니다. 2021년에는 백혈구 성분채집술 일회용품 부문이 더 큰 시장 점유율을 차지했습니다. 그러나 백혈구 성분채집 장치 부문은 2021년에서 2028년 사이에 더 높은 CAGR을 기록할 것으로 예상됩니다.



백혈구 성분채집 시장, 제품 유형별 - 2021년 및 2028년

응용 기반 통찰력



백혈구 성분채집술 시장은 애플리케이션별로 연구 애플리케이션과 치료 애플리케이션으로 나뉩니다. 2021년에는 연구 애플리케이션 부문이 시장에서 더 큰 점유율을 차지했으며 동일한 부문이 향후 몇 년 동안 더 높은 CAGR을 기록할 것으로 예상됩니다.



최종 사용자 기반 통찰력



최종 사용자에 의한 백혈구 성분채집술 시장은 제약 및 생명공학 회사, 학술 및 연구 기관, 혈액 성분 공급자 및 혈액 센터, 병원 및 수혈 센터로 분류됩니다. 2021년에는 혈액 성분 공급자와 혈액 센터 부문이 시장에서 가장 큰 점유율을 차지했습니다. 한편, 병원 및 수혈 센터 부문은 향후 몇 년 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.



전략적 통찰력



백혈구 성분채집술 시장에서 활동하는 회사는 다음과 같은 전략을 채택하고 있습니다. 제품 출시, 인수합병, 협업, 제품 혁신 및 제품 포트폴리오 확장으로 전 세계적으로 입지를 확장하고 브랜드 이름을 유지하며 최종 사용자의 증가하는 수요를 충족합니다.



백혈구 성분채집 시장 - 제품 유형별< /p>


  • 백혈구 성분채집 장치

    • 성분채집 장치

    • 백혈구 성분채집 컬럼 및 세포 분리기

    • 백혈구 제거 필터


  • 백혈구 성분채집 일회용품


백혈구 성분채집 시장 - 애플리케이션별





  • 연구 애플리케이션

  • 치료 애플리케이션

  • 백혈구 성분채집술 시장 - 최종 사용자별





    • 제약 및 생명공학 회사

    • 학술 및 연구 기관

    • 혈액 성분 공급자 및 혈액 센터< /li>
    • 병원 및 수혈 센터


    백혈구 성분채집술 시장 - 지역별





    • 북미

      • 미국

      • < li>캐나다
      • 멕시코



    • 유럽

      • 프랑스

      • 독일

      • 이탈리아

      • 영국

      • 스페인

      • 기타 유럽



    • 아시아 태평양(APAC)

        < li>중국
      • 인도

      • 한국

      • 일본

      • 호주

      • 기타 아시아 태평양


    • 중동 및 아프리카(MEA)

      • 남아프리카

      • 사우디아라비아

      • UAE

      • 기타 중동 및 아프리카



    • 남미(SAM)

      • 브라질

      • 아르헨티나

      • 나머지 of South and Central America




    회사 프로필





    • Asahi Kasei Corporation

    • Fresenius SE & Co . KGaA

    • Haemonetics Corporation

    • Terumo Corporation

    • STEMCELL Technologies Inc.

    • HemaCare

    • Macopharma
    • AllCells

    • STEMEXPRESS

    • BioIVT


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are leukapheresis?

Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields.

What are the driving factors for the leukapheresis market across the globe?

Key factors that are driving the growth of this market are number of voluntary blood donors, increasing incidence of hematologic diseases, surge in elderly population and growing demand for leukopaks in clinical research activities boost the market growth over the years.

Which product type led the leukapheresis market?

The leukapheresis disposables segment dominated the global leukapheresis market and held the largest revenue share of 61.43% in 2021.

Which end-user held the largest share in the leukapheresis market?

The blood component providers and blood centers segment dominated the global leukapheresis market and accounted for the largest revenue share of 35.03% in 2021.

Who are the key players in the leukapheresis market?

The leukapheresis market majorly consists of the players such Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation Terumo Corporation, STEMCELL Technologies Inc., HemaCare, Macopharma, AllCells, STEMEXPRESS, and BioIVT amongst others.

What is the regional market scenario of leukapheresis?

Global leukapheresis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for leukapheresis. The growth of the region is attributed to increasing product launches coupled with increasing patient population.
The Asia Pacific region is expected to account for the fastest growth in the leukapheresis market. Increase in government investments and a number of private biotechnology companies in this region contribute to this dominant share. The rising geriatric population and increasing investment in research are said to be responsible for this growth.

The List of Companies - Leukapheresis Market

  1. Asahi Kasei Corporation
  2. Fresenius SE & Co. KGaA
  3. Haemonetics Corporation
  4. Terumo Corporation
  5. STEMCELL Technologies Inc.
  6. HemaCare
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS
  10. BioIVT

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports